Showing results (61-70 of 201) with videos related to

Sort By:
Pageof 21
The Journal of Clinical Investigation|March 6, 2018
PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapyDmitriy Zamarin, Jacob M Ricca, Svetlana Sadekova, et al.
Gynecologic Oncology|February 22, 2023
Impact of immune infiltration signatures on prognosis in endometrial carcinoma is dependent on the underlying molecular subtypeKimberly Dessources, Lorenzo Ferrando, Qin C Zhou, et al.
JCO Precision Oncology|October 14, 2022
State of the Biomarker Science in Ovarian Cancer: A National Cancer Institute Clinical Trials Planning Meeting ReportJosee-Lyne Ethier, Katherine C Fuh, Rebecca Arend, et al.
Journal of Translational Medicine|August 3, 2011
The immunological potency and therapeutic potential of a prototype dual vaccine against influenza and Alzheimer's diseaseHayk Davtyan, Anahit Ghochikyan, Richard Cadagan, et al.
Oncotarget|July 10, 2018
Lysis-independent potentiation of immune checkpoint blockade by oncolytic virusAnton Oseledchyk, Jacob M Ricca, Mathieu Gigoux, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case seriesTiffany Y Sia, Vivian Wan, Michael Finlan, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 31, 2024
Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case seriesTiffany Y Sia, Vivian Wan, Michael Finlan, et al.
Gynecologic Oncology|June 9, 2020
Utility of serum CA-125 monitoring in patients with ovarian cancer undergoing immune checkpoint inhibitor therapyJulia L Boland, Qin Zhou, Alexia E Iasonos, et al.
JCO Precision Oncology|September 11, 2020
Computed Tomography-Derived Radiomic Metrics Can Identify Responders to Immunotherapy in Ovarian CancerYuki Himoto, Harini Veeraraghavan, Junting Zheng, et al.
Pageof 21